For patients with nephrogenic hypertension, the first choice of antihypertensive drugs is either the priligy or the sartan antihypertensive drugs, which have renal protective effects. The representative drugs of the priligy class include enalapril and perindopril, and the sartan antihypertensive drugs mainly include irbesartan and telmisartan. However, if renal function is severely impaired or hyperkalemia exists, these two types of drugs should not be used unless dialysis treatment is also received. Patients whose blood pressure is not controlled by any of the above antihypertensive drugs are recommended to choose the combination of calcium channel blockers. Because these drugs have relatively little effect on renal function, representative drugs include felodipine extended-release tablets, amlodipine, nifedipine controlled-release tablets, etc. At the same time, if the patient is accompanied by a rapid heart rate, beta-blockers can also be applied in combination, and the representative drugs include bisoprolol and metoprolol. If the blood pressure is still difficult to control to normal level by applying the above drugs, you can also choose to apply alpha-blockers, such as prazosin and terazosin, which relatively do not affect the kidney function either.